Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001035422-26-000010
Filing Date
2026-09-04
Accepted
2026-09-04 16:18:11
Documents
1
Period of Report
2026-09-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3105
  Complete submission text file 0001035422-26-000010.txt   5366
Mailing Address 1646 W. SNOW AVE SUITE 138 TAMPA FL 33606
Business Address 1646 W. SNOW AVE SUITE 138 TAMPA FL 33606 813-606-0060
CTT PHARMACEUTICAL HOLDINGS, INC. (Issuer) CIK: 0001035422 (see all company filings)

EIN.: 113763974 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1646 W. SNOW AVE SUITE 138 TAMPA FL 33606
Business Address 1646 W. SNOW AVE SUITE 138 TAMPA FL 33606 813-606-0060
CTT PHARMACEUTICAL HOLDINGS, INC. (Reporting) CIK: 0001035422 (see all company filings)

State of Incorp.: FL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-30651 | Film No.: 261362310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)